
    
      This trial is a prospective, randomized controlled study with blinded participant, care
      provider, investigator, and outcomes assessor. 1154 patients aged 18 to 75 years undergoing
      laparoscopic gastrointestinal surgery will be enrolled.Triple therapy of palonosetron and
      dexamethasone plus fosaprepitant will be administered in the intervention group, and double
      therapy of palonosetron and dexamethasone will be used in the control group. The anxiety of
      patients will be evaluated. The primary outcome is proportion of participants with PONV
      during the first 24 postoperative hours. Secondary outcomes are as follow: proportion of
      participants with PONV,emetic episodes, nausea, with rescue antiemetic medication; the scores
      of QOR-40; pain scores;time to first flatus after surgery; time to first defecation after
      surgery; recovery time; health related quality of life; proportion of participants with
      adverse events.
    
  